Fundraising Fox
Vertero Therapeutics, Inc.
Founded 2016 · 12 employees on LinkedIn · 5 known investors
Find your way into Vertero Therapeutics, Inc.
Sign up to find every way you can get introduced to Vertero Therapeutics, Inc.
- Your email: who you already know at Vertero Therapeutics, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vertero Therapeutics, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
Founders & leadership
Vertero Therapeutics, Inc. was founded in 2016 by Sarkis Mazmanian, PhD.
SM
Sarkis Mazmanian, PhDCo-founder and Board Member
Investors · 5
AIFlisted by AIFNew York
How we know: AIF's portfolio page · Not right? Tell us
OneVentureslisted by OneVenturesSydney · $3.3M – $13.2M
How we know: OneVentures's portfolio page · Not right? Tell us
Frequently asked questions
- What does Vertero Therapeutics, Inc. do?
- Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
- Who founded Vertero Therapeutics, Inc.?
- Vertero Therapeutics, Inc. was founded by Sarkis Mazmanian, PhD in 2016.
- Who are Vertero Therapeutics, Inc.'s investors?
- Vertero Therapeutics, Inc.'s investors include AIF, OneVentures, Seventure Partners, Taiho Ventures, LLC, UTokyo Innovation Platform Co. Ltd..